| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$41 |
azer-cel CAR-T naive data presented at ASCO Annual Meeting
|
1 Jun 2026 8:33AM |
$0.115 |
$0.083 |
fallen by
27.83%
|
|
| Epiminder Limited (EPI) ORDINARY FULLY PAID |
Health Care |
$60 |
DETECT Study reaches 25th enrolment as momentum builds
|
1 Jun 2026 8:33AM |
$0.395 |
$0.340 |
fallen by
13.92%
|
|
EPI - Price-sensitive ASX Announcement
Full Release
Key Points
- Epiminder Limited reached the 25th patient enrolment in the DETECT study.
- The DETECT study is a prospective, randomized, controlled US clinical study evaluating the Minder® System.
- 19 leading clinical sites across the United States are participating in DETECT, including Mayo Clinic, Harvard, and Stanford.
- The next enrolment target is 50 patients, expected by mid Q3 CY2026.
- DETECT addresses a gap in epilepsy care caused by inconclusive inpatient EEG monitoring.
- The study aims to enroll up to 210 participants across 25 US sites with a six-month primary follow-up.
- The primary endpoint is the proportion of subjects achieving an actionable clinical event.
- Minder® System provides continuous bilateral subscalp EEG monitoring.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rivco Australia Ltd (RIV) ORDINARY FULLY PAID |
Utilities |
$215 |
Update - Notification of buy-back - RIV
|
1 Jun 2026 8:32AM |
$1.430 |
$1.360 |
fallen by
4.90%
|
|
| Theta Gold Mines Limited (TGM) ORDINARY FULLY PAID |
Materials |
$241 |
TGM Secures US$90M Bond Issue - Pathway to Gold Production
|
1 Jun 2026 8:32AM |
$0.210 |
$0.180 |
fallen by
14.29%
|
|
TGM - Price-sensitive ASX Announcement
Full Release
Key Points
- US$90 million Senior Secured Callable Bond issued.
- Funding directed towards TGME Gold Mine Project in South Africa.
- Plant commissioning targeted for late 2026.
- First gold production expected in Q1 2027.
- No mandatory hedging or options as part of financing.
- Four-year bond tenor with interest-only payments initially.
- Proceeds used for construction and mine development.
- Bond to be listed on Euronext Nordic ABM.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$694 |
Weekly NTA Estimate
|
1 Jun 2026 8:31AM |
$2.850 |
$3.030 |
risen by
6.32%
|
|
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$59 |
Proposed issue of securities - BLG
|
1 Jun 2026 8:31AM |
$0.290 |
$0.310 |
risen by
6.90%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$5,668 |
Update - Notification of buy-back - AMP
|
1 Jun 2026 8:30AM |
$1.595 |
$2.330 |
risen by
46.08%
|
|
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$328 |
Update - Notification of buy-back - PAC
|
1 Jun 2026 8:30AM |
$10.880 |
$11.730 |
risen by
7.81%
|
|
| Astron Corporation Limited (ATR) ORDINARY FULLY PAID |
Materials |
$196 |
Appointment of Non-Executive Director
|
1 Jun 2026 8:30AM |
$0.558 |
$0.455 |
fallen by
18.39%
|
|
| Green & Gold Minerals Limited (GG1) ORDINARY FULLY PAID |
Materials |
$9 |
High grade rock chip assays as drilling begins at Herberton
|
1 Jun 2026 8:30AM |
$0.135 |
$0.145 |
risen by
7.41%
|
|
GG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade rock chip assay results reported from Copper Hills and Mt Gossan.
- Drilling began in late May 2026 at Herberton Mineral Field, Queensland.
- Targets include copper, silver, tin, indium, and gold.
- Mt Gossan breccia shows significant tin and indium grades with elevated gold values.
- Copper grades range from 0.1% to 0.4% in the leached iron oxide cap.
- Exploration includes both new and historical data.
- Notifications made to native title holders for planned exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$286 |
Update - Notification of buy-back - AMH
|
1 Jun 2026 8:30AM |
$0.900 |
$0.910 |
risen by
1.11%
|
|
| Liberty Financial Group (LFG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$990 |
Dividend/Distribution - LFG
|
1 Jun 2026 8:29AM |
$3.140 |
$3.260 |
risen by
3.82%
|
|
| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$7,096 |
Update - Notification of buy-back - ARG
|
1 Jun 2026 8:29AM |
$8.940 |
$9.430 |
risen by
5.48%
|
|
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$215 |
Infinity Group Recovery and Earnings Update
|
1 Jun 2026 8:29AM |
$0.150 |
$0.130 |
fallen by
13.33%
|
|
PGC - Price-sensitive ASX Announcement
Full Release
Key Points
- Paragon Care Limited provided an update on the Infinity Group receivership.
- A 100% provision was recognized for amounts owed by Infinity Group.
- Preliminary analysis indicates a potential recovery of 24% to 32.5% of the exposure, amounting to A$11.7m to A$15.8m.
- Paragon Care has received A$3.4m from the ATO for GST previously paid.
- Forecasted revenue for FY26 is approximately A$3.7 billion.
- Underlying EBITDA is expected to be between A$95m to A$100m.
- Net debt expected to be between 2 to 2.5 times EBITDA.
- Challenges include logistics costs and pricing pressures from rising oil prices.
- Paragon Care focuses on cost management and working capital optimization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liberty Financial Group (LFG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$990 |
Quarterly Distribution
|
1 Jun 2026 8:29AM |
$3.140 |
$3.260 |
risen by
3.82%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,980 |
Update - Notification of buy-back - MGH
|
1 Jun 2026 8:29AM |
$5.100 |
$5.480 |
risen by
7.45%
|
|
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$59 |
Proposed issue of securities - BLG
|
1 Jun 2026 8:29AM |
$0.290 |
$0.310 |
risen by
6.90%
|
|
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$59 |
BluGlass executes $1 million Option shortfall agreement
|
1 Jun 2026 8:29AM |
$0.290 |
$0.310 |
risen by
6.90%
|
|
BLG - Price-sensitive ASX Announcement
Full Release
Key Points
- BluGlass secures $1 million with potential additional $500,000 through Option shortfall agreement
- Funds to support GaN laser contracts and working capital
- Agreement includes issuance of up to 5,769,230 shares at $0.26
- Shares come with free-attaching options exercisable at $0.38
- Amery Partners Pty Ltd to receive 6% fee for raised funds
- Strengthens BluGlass's financial position following $8 million placement
- Reflects growing confidence in BluGlass's technology and commercial potential
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$777 |
Update - Notification of buy-back - DJW
|
1 Jun 2026 8:27AM |
$2.800 |
$2.970 |
risen by
6.07%
|
|
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$2 |
CHM announces positive Phase 1/2 data at ASCO
|
1 Jun 2026 8:27AM |
$0.100 |
$0.040 |
fallen by
60%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics announced positive Phase 1/2 data for CHM CDH17 at ASCO.
- 82% of evaluable patients achieved stable disease per RECIST criteria.
- CHM CDH17 showed expansion and persistence in peripheral blood of all treated patients.
- CHM CDH17 is tolerable in heavily pre-treated metastatic patients.
- Ongoing enrollment at Dose Level 3 with an anticipated Phase 2 dose recommendation.
- The trial targets advanced colorectal, gastric, and intestinal neuroendocrine tumors.
- CHM CDH17 is a novel CAR-T cell therapy targeting CDH17, a cancer biomarker.
- The trial seeks to determine the recommended Phase 2 dose and evaluate objective response rate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$157 |
Jade Books First Ever Gas Reserve in Mongolia
|
1 Jun 2026 8:27AM |
$0.086 |
$0.071 |
fallen by
17.44%
|
|
JGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Jade Gas Holdings Ltd's maiden gas reserves approved in Mongolia
- First-ever approval of natural gas reserves in Mongolia
- Enables lodging of Plan for Development and Operations (PDO)
- Allows application for a Production Licence
- Significant de-risking and value accretion for the TTCBM Project
- Covers 4.2 km2 of the Red Lake Field area
- Key step in Mongolia's energy transition
- Jade Gas focuses on coal bed methane potential in Mongolia
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Collins Foods Limited (CKF) ORDINARY FULLY PAID |
Consumer Discretionary |
$962 |
Initial Director's Interest Notice - Scott
|
1 Jun 2026 8:26AM |
$8.820 |
$8.140 |
fallen by
7.71%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,932 |
Net Tangible Asset Backing
|
1 Jun 2026 8:26AM |
$4.490 |
$4.620 |
risen by
2.90%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$10 |
Awarded Eastern Freeway Contract
|
1 Jun 2026 8:26AM |
$0.115 |
$0.140 |
risen by
21.74%
|
|
FOS - Price-sensitive ASX Announcement
Full Release
Key Points
- FOS Capital Limited awarded the Eastern Freeway contract via its Aldridge Traffic Systems subsidiary.
- The contract is for supplying ITS roadway lighting and control equipment for the NELP Eastern Freeway Upgrades.
- The contract value is $0.5 million.
- The ATS High Mast Fitting will be a key fixture supplied, noted for its improved performance and lighter weight.
- FOS is also providing the 'TST' Traffic Smart City Technology Intelligent Traffic System.
- ATS underwent a transformative restructure after its acquisition in June 2025.
- This contract is the largest project for ATS since its acquisition.
- FOS Capital's total order book has reached $9 million.
- FOS Capital is a manufacturer and distributor of commercial, industrial, and architectural lighting solutions with operations in Brisbane and Sydney.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$675 |
Tivan delivers Australian first pilot program at Speewah
|
1 Jun 2026 8:26AM |
$0.295 |
$0.290 |
fallen by
1.69%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Tivan delivers successful pilot program for Speewah.
- Produced 195 kg of acid-grade fluorspar at 98.6% CaF2.
- Exceeded benchmark acidspar specification of 97% CaF2.
- Supports Definitive Feasibility Study and product marketing.
- Collaboration with Sumitomo Corporation for global distribution.
- Plans for full-scale piloting later this year.
- Progress on Australia's first fluorite mining and processing operation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.